Aug 07, 2020 / 08:30AM GMT
Sigurdur Oli Olafsson - Hikma Pharmaceuticals PLC - CEO & Executive Director
So good morning, everyone, and welcome. Welcome anyway to Hikma's first half investor call. As you know, today, we will not be giving a presentation on this call as we posted it on our website at 8:00 this morning. So here today is myself, Siggi Olafsson, CEO of Hikma Pharmaceuticals. And with me is Khalid Nabilsi, the CFO of Hikma. So we will be answering questions throughout the call. I just need to read the Zoom ethics, how you ask the question. (Operator Instructions)
So with that, I just want to say we are very pleased with the results, a good start to the year. All 3 businesses performed about our expectation at the beginning of the year, many ins and outs. But why don't we start with questions. I'm happy to take anyone. Who wants to be first?
Questions and Answers:
Unidentified Company Representative -So we have a first question from someone on the phone. So I'm just going to unmute you. Please ask your question.
Patrick Andrew Robert Wood -